Welcome to our dedicated page for Else Nutrition H news (Ticker: BABYF), a resource for investors and traders seeking the latest updates and insights on Else Nutrition H stock.
Else Nutrition Holdings Inc. (BABYF) delivers plant-based nutritional solutions through innovative products for children and adults. This dedicated news hub provides investors and stakeholders with essential updates about corporate developments and market activities.
Access authoritative information including quarterly earnings announcements, regulatory filings, and strategic partnership updates. Our curated collection features official press releases about product launches, retail expansions, and nutritional research breakthroughs.
Discover updates about BABYF's clean-ingredient formulations, distribution network growth, and sustainability initiatives. Content types include financial performance reports, executive leadership changes, and regulatory milestone achievements.
Bookmark this page for streamlined access to BABYF's evolving story in plant-based nutrition. Verify facts directly from primary sources and stay informed about this innovative company's trajectory.
Else Nutrition Holdings Inc. (TSX: BABY) (OTCQX: BABYF) has launched 'Formula for Change,' a campaign to accelerate U.S. regulatory support for clinical trials of its dairy-free, soy-free infant formula. The initiative builds on Operation Stork Speed, a federal effort to fast-track next-generation infant formula development.
The company has developed the world's first infant formula based on whole plant ingredients, including almonds and buckwheat, which mirrors human milk's nutritional profile and holds the Clean Label Project Purity Award. While available internationally, U.S. regulations currently prevent clinical trials required for approval.
Key campaign objectives include:
- Modernizing outdated U.S. regulatory pathways
- Addressing market concentration dominated by four companies
- Providing alternatives for babies intolerant to dairy/soy
- Creating solutions following the 2022-2023 formula shortage crisis
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) has announced a bi-weekly default status report following the implementation of a Management Cease Trade Order (MCTO) granted by the British Columbia Securities Commission. The MCTO was issued due to delays in completing audit procedures for the company's annual financial statements, MD&A, and AIF for the year ended December 31, 2024.
The order restricts trading activities for the CEO and CFO until the Annual Filings are submitted and the MCTO is lifted, while other shareholders maintain their trading abilities. The company is actively working with auditors to complete the audit and expects to file the required documents by April 23, 2025, with a final deadline of May 30, 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) has been granted a voluntary management cease trade order by the British Columbia Securities Commission. The company is unable to file its annual financial statements, MD&A, and AIF for the year ended December 31, 2024, within the required 90-day period due to timing constraints in completing audit procedures.
The company expects to file these documents by April 9, 2025, and no later than May 30, 2025. During this period, the company will issue bi-weekly default status reports. The cease trade order specifically prohibits the CEO and CFO from trading company securities but does not affect other persons' ability to trade. The company confirms it is not subject to any insolvency proceedings.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) has announced the rescheduling of its 2024 fiscal year business update conference call. The call was originally planned for March 31, 2025, at 10:00 a.m. Eastern Time. The company will announce the new date and time in a future news release.
Else Nutrition Holdings (BABYF) has announced a business update conference call scheduled for March 31, 2025 at 10:00 a.m. Eastern Time. The call will discuss the company's financial results for the 2024 fiscal year ended December 31, 2024, along with corporate progress and other developments.
The conference call will be accessible via toll-free telephone numbers and a webcast. U.S. callers can dial 1-877-407-9219, while international callers can use +1-201-689-8852. The webcast replay will be available on the company's Investor Relations website through March 31, 2026. A telephone replay will be accessible until April 14, 2025, using conference ID: 13752367.
Else Nutrition Holdings (BABYF) welcomes the launch of Operation Stork Speed, a strategic initiative by the U.S. Department of Health and Human Services (HHS) and FDA aimed at expanding infant formula options. The company is actively pursuing the development of the first whole food, plant-based infant formula in the United States.
The company has established a presence in Washington D.C., engaging a healthcare lobbying firm and conducting bipartisan Congressional meetings. These efforts have led to Congressional oversight on modernized FDA guidance for plant-based, non-soy, non-dairy infant formula options.
This development follows the FDA's January 2025 release of their Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. Else Nutrition's formula focuses on using natural ingredients like almonds, buckwheat, and tapioca to create clean-label alternatives for early childhood nutrition.
Else Nutrition (BABYF) has announced its entry into the adult nutrition market with the launch of plant-based ready-to-drink (RTD) nutritional shakes in the U.S. and Canada. The product represents the first whole-food, plant-powered complete nutrition drink for adults in these markets.
The RTD shakes, made from ingredients like almond butter, sunflower protein flour, and buckwheat flour, offer 280 calories and 14g of protein per serving, along with 26 essential vitamins and minerals. The product contains 50% less sugar than leading competitors and is Clean Label Project Certified.
Initially launching with Vanilla flavor in Canada through Amazon.ca and select retailers in 8 fl. oz. tetra packs (6 and 24-pack options), the U.S. launch is scheduled for Q2 2025. The launch aligns with market trends, as the U.S. dairy alternatives market is projected to grow from $5.84 billion in 2022 to $14.28 billion by 2030.
Else Nutrition reported Q3 2024 financial results with revenue increasing 5% year-over-year to $1.8 million, compared to $1.71 million in Q3 2023. Operating expenses were $3.6 million, up from $3.5 million in the previous year. The company's cash balance stood at $0.9 million as of September 30, 2024.
The company is expanding its retail presence through a pilot program with Costco, potentially leading to distribution in over 100 Canadian locations. Additionally, they're finalizing arrangements to offer kids RTD products in 900+ new US grocery stores. Else is also preparing to launch its Adult RTD product, with first commercial production scheduled for late 2024.
Else Nutrition Holdings has launched a 12-week pilot program with a multinational wholesale retailer to introduce its Plant-Powered Ready-to-Drink Kids Nutrition Shakes in 11 warehouse locations across Canada. The program features endcap displays and product sampling demos, aiming to validate demand for a potential national rollout in 2025. The initiative serves as a strategic entry point for both Canadian market expansion and potential entry into the United States.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) has announced a business update conference call scheduled for November 14, 2024 at 10:00 a.m. Eastern Time. The call will discuss the company's third quarter 2024 financial results for the period ended September 30, 2024, along with corporate progress and developments. The conference will be accessible via telephone and webcast, with replay options available through November 14, 2025. Participants can submit questions via email to baby@crescendo-ir.com.
